NICE, Cochrane to collaborate on delivery of ‘living’ recommendations
Agreement will allow NICE to make ‘efficient and effective’ updates to recommendations in its guideline portfolio
Read More
Tag: Cochrane
- R1 Therapeutics launches with $77.5m to advance hyperphosphatemia treatment
- Taiwan Bio partners with Terumo to advance automated Treg manufacturing
- Elevara begins phase 2b trial of ELV001 in rheumatoid arthritis
- Lebrikizumab shows strong results for children with atopic dermatitis
- MHRA approves new treatment for severe alopecia areata
